Matthias May
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthias May has a total of 537 co-authors. Here are the top co-authors by number of shared publications:
Maximilian Burger
Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany
32 shared publications- Christian Gilfrich
Department of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, 94315 Straubing, Germany
28 shared publications Christian Gilfrich
Department of Urology, St. Elisabeth Hospital Straubing, Medical Campus Lower Bavaria, Straubing, Germany
26 shared publications- Ingmar Wolff
Department of Urology, University Medicine Greifswald, Greifswald, Germany
26 shared publications Sabine Brookman-May
Department of Urology, Ludwig Maximilians University (LMU), Munich, Germany
25 shared publicationsIngmar Wolff
16 shared publications
Latest Publications
- 28 October 2026
- Published by Elsevier in European Urology Focus
Re: Grace McKinney, Mette Bach Larsen, Angel Gomez Amorin, et al. "I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update. Eur Urol Focus. 2026 Aug 5:S2405-4569(26)00168-9. doi: 10.1016/j.euf.2026.07.015. Epub ahead of print. PMID: 42557178
- 28 October 2026
- Published by Elsevier in European Urology Focus
Re: Grace McKinney, Mette Bach Larsen, Angel Gomez Amorin, et al. "I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update. Eur Urol Focus. 2026 Aug 5:S2405-4569(26)00168-9. doi: 10.1016/j.euf.2026.07.015. Epub ahead of print. PMID: 42557178
- Open Access
- 20 October 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e96886
From Divergent Guidelines to Delphi-Ready Items: Tutorial for Large Language Model–Assisted Guideline Harmonization Using Penile Cancer as a Worked Example
Background: Clinical practice guidelines are central instruments of evidence-based care; yet, in many domains, particularly rare or complex diseases, multiple guidelines coexist and frequently offer conflicting advice. Existing strategies for resolving such divergences are often labor-intensive, opaque, and insufficiently reproducible. Objective: This tutorial aimed to develop and demonstrate a reproducible workflow for transforming divergent clinical guideline recommendations and literature-derived white areas into human-reviewed Delphi-ready candidate items. Methods: Following a step-by-step tutorial structure, we demonstrate the workflow using penile cancer as a worked example. The process comprises manual selection of clinical guidelines, a systematic PubMed search for literature-derived candidate issues potentially unaddressed by the selected guidelines, selection of 3 complementary large language models (LLMs), and execution of predefined prompts, multimodal recommendation extraction, semantic harmonization, and item-level guideline stance classification. The evaluative process combines a 3-LLM ensemble consistency check with an independent pre-Delphi appraisal by 4 penile cancer experts using a predefined 5-point suitability scale and acceptance threshold. Results: In the worked example in the field of penile cancer as a high-stakes use case, the workflow extracted 157 clinical recommendations from 5 guidelines and consolidated them into 68 harmonized guideline-derived items. Stance classification identified 15 uniformly supported items and 53 divergent, ambiguous, or incompletely addressed items. In parallel, literature processing generated 95 harmonized white-area items, of which 9 were classified as true white-area items not addressed by the included guidelines. The final methodological output was a set of 62 human-reviewed Delphi-ready candidate items for subsequent clinical consensus voting. Conclusions: This methodology provides a scalable, transparent, and transferable approach for identifying and structuring interguideline inconsistencies and evidence gaps. By combining LLM-assisted analysis with independent external expert appraisal, it supports the reproducible transformation of heterogeneous guideline content into Delphi-ready candidate items.
- 20 October 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e96886
Open AccessFrom Divergent Guidelines to Delphi-Ready Items: Tutorial for Large Language Model–Assisted Guideline Harmonization Using Penile Cancer as a Worked Example
Background: Clinical practice guidelines are central instruments of evidence-based care; yet, in many domains, particularly rare or complex diseases, multiple guidelines coexist and frequently offer conflicting advice. Existing strategies for resolving such divergences are often labor-intensive, opaque, and insufficiently reproducible. Objective: This tutorial aimed to develop and demonstrate a reproducible workflow for transforming divergent clinical guideline recommendations and literature-derived white areas into human-reviewed Delphi-ready candidate items. Methods: Following a step-by-step tutorial structure, we demonstrate the workflow using penile cancer as a worked example. The process comprises manual selection of clinical guidelines, a systematic PubMed search for literature-derived candidate issues potentially unaddressed by the selected guidelines, selection of 3 complementary large language models (LLMs), and execution of predefined prompts, multimodal recommendation extraction, semantic harmonization, and item-level guideline stance classification. The evaluative process combines a 3-LLM ensemble consistency check with an independent pre-Delphi appraisal by 4 penile cancer experts using a predefined 5-point suitability scale and acceptance threshold. Results: In the worked example in the field of penile cancer as a high-stakes use case, the workflow extracted 157 clinical recommendations from 5 guidelines and consolidated them into 68 harmonized guideline-derived items. Stance classification identified 15 uniformly supported items and 53 divergent, ambiguous, or incompletely addressed items. In parallel, literature processing generated 95 harmonized white-area items, of which 9 were classified as true white-area items not addressed by the included guidelines. The final methodological output was a set of 62 human-reviewed Delphi-ready candidate items for subsequent clinical consensus voting. Conclusions: This methodology provides a scalable, transparent, and transferable approach for identifying and structuring interguideline inconsistencies and evidence gaps. By combining LLM-assisted analysis with independent external expert appraisal, it supports the reproducible transformation of heterogeneous guideline content into Delphi-ready candidate items.
- Open Access
- 12 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (11) , 1088
Defining benefit from lifestyle interventions during active surveillance
- 12 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (11) , 1088
Open AccessDefining benefit from lifestyle interventions during active surveillance
- 5 September 2026
- Published by S. Karger AG in Urologia Internationalis
- p. 1
Pelvic Lymph Node Dissection at Radical Prostatectomy: Patterns of Failure and Decision Impact
- 5 September 2026
- Published by S. Karger AG in Urologia Internationalis
- p. 1
Pelvic Lymph Node Dissection at Radical Prostatectomy: Patterns of Failure and Decision Impact
- Open Access
- 1 August 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (8) , 260
Beyond staging: toward a layered risk architecture after radical cystectomy for bladder cancer
Beyond staging: toward a layered risk architecture after radical cystectomy for bladder cancer
- 1 August 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (8) , 260
Open AccessBeyond staging: toward a layered risk architecture after radical cystectomy for bladder cancer
Beyond staging: toward a layered risk architecture after radical cystectomy for bladder cancer
- 16 July 2026
- Published by Elsevier in European Urology
Re: Prostate-specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer
- 16 July 2026
- Published by Elsevier in European Urology
Re: Prostate-specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer
- Open Access
- 1 June 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (6) , 192
Biological fit and clinical utility in upper tract urothelial carcinoma diagnostics: positioning Oncuria-Detect within an evidence-based, layered biomarker framework
Biological fit and clinical utility in upper tract urothelial carcinoma diagnostics: positioning Oncuria-Detect within an evidence-based, layered biomarker framework
- 1 June 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (6) , 192
Open AccessBiological fit and clinical utility in upper tract urothelial carcinoma diagnostics: positioning Oncuria-Detect within an evidence-based, layered biomarker framework
Biological fit and clinical utility in upper tract urothelial carcinoma diagnostics: positioning Oncuria-Detect within an evidence-based, layered biomarker framework
- 12 May 2026
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 24 (5) , 102579
Surgical Reporting and Prognostic Stratification in Urachal Adenocarcinoma: Considerations Arising From a Recent Single-center Cohort Study
- 12 May 2026
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 24 (5) , 102579
Surgical Reporting and Prognostic Stratification in Urachal Adenocarcinoma: Considerations Arising From a Recent Single-center Cohort Study
- Open Access
- 6 May 2026
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 61, 163-165
Sweden’s nationwide transition to transperineal prostate biopsy: implications for implementation across Europe
- 6 May 2026
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 61, 163-165
Open AccessSweden’s nationwide transition to transperineal prostate biopsy: implications for implementation across Europe